Press Office Articles

MmRNA Scientific Colloquium on vaccine access and equity on the African Continent

0 Comments

MmRNA Scientific Colloquium on vaccine access and equity on the African Continent On Monday 27 November in Capetown, South Africa at #Afrigen, the 3rd Scientific Colloquium dived into the current thinking

Read Full

There will be a dedicated day focused on RNA Technology

0 Comments

There will be a dedicated day focused on RNA Technology at Biomolecular Horizons 2024 Horizons. CEO of Afrigen Biologics, Dr. Petro Terblanche will be a main speaker! Join us at #BMH2024 in Melbourne 22-26 Sept

Read Full

Gimhae Geneuintech Co.,Ltd developed ‘multifunctional cancer treatment

0 Comments

8 Park Joon-eon I 0 Approved 2023.10.12 17:57   Applied to the treatment of both blood cancer and solid cancer, and promoted commercialization with South African companies   A company

Read Full

World Bank approves plan to boost health emergency response

0 Comments

Click here to read more ⬇ https://lnkd.in/dkbedyHZ #afrigen #afrigenbiologics #WorldBank

Read Full

Gates gives $40 million to boost access to mRNA vaccines in Africa

0 Comments

⬇️⬇️⬇️⬇️ https://lnkd.in/dEzpMnGv #afrigen #mRNA #vaccines

Read Full

University of Wisconsin-Madison graduate student Elizabeth Appelt 

0 Comments

University of Wisconsin-Madison graduate student Elizabeth Appelt laid the foundation that led UW leaders Brian Fox, chair of the University of Wisconsin–Madison Department of Biochemistry, and Jorge Osorio, director of the University of Wisconsin-Madison Global Health

Read Full

| PRODUCT POST |

0 Comments

#CrampRelief by #afrigen 🔹If you’ve ever been awakened in the night or stopped in your tracks by a sudden charley horse, you know that muscle cramps can cause severe pain. Almost everyone

Read Full

PRESS RELEASE

0 Comments

Evaxion Partners With Pharmaceutical Company #Afrigen Biologics to Develop Novel #mRNA Vaccine Against Gonorrhea ➡ Partnership based on a highly protective #vaccine candidate identified by Evaxion Biotech A/S’s EDENTM platform ➡ The collaboration will access mRNA technology

Read Full